Lotus Pharmaceutical Co., Ltd.
TWSE:1795.TW
282 (TWD) • At close November 14, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lotus Pharmaceutical Co., Ltd. |
Symbool | 1795.TW |
Munteenheid | TWD |
Prijs | 282 |
Beurswaarde | 74,784,708,000 |
Dividendpercentage | 1.23% |
52-weken bereik | 210.5 - 347 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Petar Antonov Vazharov |
Website | https://www.lotuspharm.com.tw |
An error occurred while fetching data.
Over Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (TWD)
Cijfers zijn in miljoenen (TWD)